Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NewGen Therapeutics patents new agents for cancer

Dec. 20, 2012

Ciclopiroxolamine evaluated in patients with hematological malignancies

Dec. 20, 2012

Lorus Therapeutics and Brock University to develop novel anticancer drugs

Dec. 19, 2012

In vitro A-1014907 data show promise in multiple myeloma

Dec. 19, 2012

MacroGenics discloses novel diabodies for the treatment of cancer

Dec. 19, 2012

Roche's Perjeta receives CHMP recommendation for approval

Dec. 18, 2012

Intracellular mechanisms of glycolysis-mediated tumor growth discovered

Dec. 18, 2012

Bayer Intellectual Property describes novel MKNK1 inhibitors

Dec. 18, 2012

Spanish researchers synthesize new protein kinase inhibitors

Dec. 18, 2012

Japanese researchers present novel adenovirus vectors for cancer

Dec. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.